NCT01144338: A reported trial by AstraZeneca
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT01144338 |
|---|---|
| Title | Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus. |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | June 18, 2010 |
| Completion date | April 21, 2017 |
| Required reporting date | April 21, 2018, midnight |
| Actual reporting date | April 13, 2018 |
| Date last checked at ClinicalTrials.gov | July 16, 2025 |
| Days late | None |